What is the current share price of JFL Life Sciences Ltd-RE (JFL-RE)?

As of the latest market update, JFL Life Sciences Ltd-RE (JFL-RE) is trading at ₹0.1. The stock has moved 33.33% down in the recent session.

What is the technical sentiment for JFL-RE stock?

Based on our proprietary technical analysis, the current signal for JFL-RE is "Neutral". This analysis considers over 20+ indicators including RSI, MACD, and moving average crossovers to gauge market momentum.

What is the 52-week high and low for JFL Life Sciences Ltd-RE?

JFL Life Sciences Ltd-RE has seen a 52-week high of ₹0.15 and a 52-week low of ₹0.1. Comparing the current price to these levels helps investors understand the stock's relative valuation and volatility over the past year.

Which sector does JFL Life Sciences Ltd-RE belong to?

JFL Life Sciences Ltd-RE operates in the Healthcare sector, specifically within the Pharmaceuticals & Biotechnology industry. Its performance is often influenced by broader trends in the Healthcare segment.

What is the market capitalization of JFL-RE?

JFL Life Sciences Ltd-RE (JFL-RE) has a market capitalization of approximately ₹0 Cr. This classifies it as a small cap stock in the Indian market.

JFL-RE

NSE

JFL Life Sciences Ltd-RE (SMALL CAP)

Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals

₹0.10

0.05 (33.33%)

As on 18 Mar 2026

Advanced Chart

Price History

Market Cap

The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.

₹0 Cr

SMALL CAP

P/E Ratio

Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.

N/A

Industry

The specific business sector the company operates in. Useful for comparing with similar companies.

Pharmaceuticals

52-Week Range

The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.

52W Low₹0.1+0.0%

52W High₹0.15-33.3%

Current Price

₹0.10

Circuit Limits (40%)

The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.

Lower Circuit₹0.06

Upper Circuit₹0.14

Reference Price

₹0.10

Investment Checklist

Analysis data not available yet

Technical Analysis

Financials

Financial data not available

Peer Comparison

Pharmaceuticals

Peer Comparison

Symbol	Name	Price	Change
SUNPHARMA	Sun Pharmaceutical Industries Limited	₹1,807.70	+0.75%
DIVISLAB	Divi's Laboratories Limited	₹6,638.00	-0.26%
TORNTPHARM	Torrent Pharmaceuticals Limited	₹4,571.20	-0.02%
CIPLA	Cipla Limited	₹1,389.40	+0.44%
ZYDUSLIFE	Zydus Lifesciences Limited	₹1,104.70	-0.11%
DRREDDY	Dr. Reddy's Laboratories Limited	₹1,275.40	-0.05%
LUPIN	Lupin Limited	₹2,293.30	+0.88%
MANKIND	Mankind Pharma Limited	₹2,381.10	+0.35%
AUROPHARMA	Aurobindo Pharma Limited	₹1,472.80	+0.59%
LAURUSLABS	Laurus Labs Limited	₹1,394.30	+0.25%

Corporate Information

Large Deals

View All

Bulk, Block and Short deals reported for this stock.

Loading Deals...

Corporate Events

Upcoming results & meetings

View All

No upcoming events found

We couldn't find any scheduled corporate actions for this symbol at the moment.

Latest News

News for JFL-RE

View All

Anupam Rasayan becomes world's first to make ETFA using flow chemistry

positive

ET Markets - Industry 23h ago

Anupam Rasayan becomes world's first to make ETFA using flow chemistry

Anupam Rasayan India Ltd has achieved a global first by commercialising Ethyl trifluoroacetate production using its unique continuous flow chemistry technology. This advanced method offers enhanced safety and efficiency over traditional batch processes. ETFA is a vital component for pharmaceuticals and life sciences.

ALIVUSANURASGLOBALJFLLIFEJFL-RERPGLIFESAILIFESUVENVITALChemicalsConsumer Services

Read full story

positive

LiveMint - Markets 1d ago

Multibagger Anupam Rasayan stock to be in focus on Friday on ETFA manufacturing milestone

Anupam Rasayan India announces commercialization of ETFA production via a proprietary continuous flow chemistry platform, making it the first globally to do so. The market potential for ETFA is $500-600 million, crucial for fluorinated compounds in pharmaceuticals and life sciences.

ALIVUSANURASFOCUSJFLLIFEJFL-RERPGLIFESAILIFESUVENChemicalsConsumer Durables

Read full story

positive

Business Standard - Markets 2d ago

Analysts project up to 17% upside in healthcare stocks trading at new highs

Apollo Hospitals, Aster DM Healthcare, Sai Life Sciences have rallied up to 27% thus far in FY27; technical analysts remain bullish on these stocks given the favourable chart set-up.

ALIVUSAPOLLOAPOLLOHOSPASTERDMHCGHCG-REHEALTHCAREHEALTHYJFLLIFEJFL-REJLHLRPGLIFESAILIFESUVENCapital GoodsFinancial Services

Read full story

JFL-RE

Price History

Investment Checklist

Technical Analysis

Financials

Peer Comparison

Peer Comparison

Corporate Information

Large Deals

Corporate Events

Latest News

News for JFL-RE

Anupam Rasayan becomes world's first to make ETFA using flow chemistry

Multibagger Anupam Rasayan stock to be in focus on Friday on ETFA manufacturing milestone

Analysts project up to 17% upside in healthcare stocks trading at new highs

Frequently Asked Questions

What is the current share price of JFL Life Sciences Ltd-RE (JFL-RE)?

What is the technical sentiment for JFL-RE stock?

What is the 52-week high and low for JFL Life Sciences Ltd-RE?

Which sector does JFL Life Sciences Ltd-RE belong to?

What is the market capitalization of JFL-RE?